BioLife Solutions, Inc.
BLFS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $28 | $25 | $24 | -$3 |
| % Growth | 10.4% | 6.2% | 799.2% | – |
| Cost of Goods Sold | $9 | $9 | $8 | $12 |
| Gross Profit | $19 | $16 | $16 | $8 |
| % Margin | 66.9% | 64.6% | 65.9% | -241.6% |
| R&D Expenses | $3 | $3 | $2 | $1 |
| G&A Expenses | $12 | $11 | $12 | $7 |
| SG&A Expenses | $15 | $14 | $14 | $6 |
| Sales & Mktg Exp. | $3 | $3 | $3 | -$1 |
| Other Operating Expenses | $1 | $16 | $1 | -$23 |
| Operating Expenses | $18 | $33 | $17 | -$17 |
| Operating Income | $1 | -$17 | -$1 | $1 |
| % Margin | 2.2% | -65.5% | -5.1% | -40.5% |
| Other Income/Exp. Net | $0 | $1 | $1 | $0 |
| Pre-Tax Income | $1 | -$16 | -$0 | $2 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $1 | -$16 | -$0 | $12 |
| % Margin | 2.2% | -62.3% | -1.9% | -363.9% |
| EPS | 0.01 | -0.33 | -0.01 | 0.27 |
| % Growth | 103% | -3,373.7% | -103.5% | – |
| EPS Diluted | 0.01 | -0.33 | -0.01 | 0.26 |
| Weighted Avg Shares Out | 48 | 48 | 47 | 47 |
| Weighted Avg Shares Out Dil | 49 | 48 | 47 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $0 |
| Interest Expense | $1 | $0 | $0 | -$0 |
| Depreciation & Amortization | $1 | $1 | $1 | $2 |
| EBITDA | $3 | -$14 | $0 | $7 |
| % Margin | 9.1% | -56.4% | 0.7% | -197.1% |